|
|
| Maladies Infectieuses > Etude de marché sectorielle |
| Deals and alliances in infectious diseases |
|
|
|
|
€ 1 995,00 |
Editeur
: |
Bridgehead |
Langue
: |
Anglais |
Date de publication : |
Avril 2006 |
Taille du document : |
1458 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 51 pages | Septembre 2008 | Anglais
|
|
|
| Main
focus: |
infectious diseases,infectious disease,vaccine,...,...
|
| Research
focus: |
industry structure,market segmentation, |
| Geographic
focus: |
usa,india,united kingdom,kenya,indonesia,... |
| |
|
|
|
|
| 68 pages | Février 2000 | Anglais
|
|
|
| Main
focus: |
infectious diseases,hepatitis b,vaccine,vaccines,...,...
|
| Research
focus: |
market segmentation,market outlook, |
| Geographic
focus: |
palestinia,usa,israel,egypt,jordan,china,syria,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Antivirals Market Outlook: Market analysis of future growth and leading players by sector
178 pages | Janvier 2005 |
Business Insights have teamed up with IMS Health to bring you, ‘The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an |
2 443,75 €
|
| |
| |
Lower Detection Limits of HBV DNA Assays
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Lower Detection Limits of HBV DNA Assays
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
HIV/AIDS Testing
340 pages | Octobre 2005 |
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands of Units.
The Product segments analyzed include HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Moni |
2 308,00 €
|
| |
| |
Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution
237 pages | Avril 2005 |
IntroductionLess than 50% of chronically infected hepatitis C patients do not benefit from the current standard of care, pegylated interferon plus ribavirin.
In the short-term, the treatment landsc |
9 120,00 €
|
| |
| |
Monoclonal Antibody Therapies: Sector Analysis Tool
pages | Avril 2005 |
IntroductionThe mAb Sector Analysis Tool presents the marketed and R&D portfolios, technology focus and product development strategies of over 100 key players in the mAbs market.
In addition, you c |
6 080,00 €
|
| |
| |
Recommendations for Diagnostic Testing for Hepatitis B
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Chinese Markets for HIV Drugs
190 pages | Janvier 2003 |
China's demand for HIV drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend |
2 835,00 €
|
| |
| |
Pipeline Insight: Hepatitis B - New Kids on the Block
211 pages | Avril 2005 |
IntroductionAccording to the WHO, 350-400 million people are chronically infected with HBV progresses to liver cirrhosis and hepatocellular carcinoma.
Previously HBV has been treated with lamivudin |
9 120,00 €
|
| |
| |
Recommendations for Diagnostic Testing for Hepatitis C
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Deals and alliances in infectious diseases |
|
|
Partneringdesk deals and alliances in infectious diseases provides an in-depth view of over 1600 deals and alliances announced in infectious diseases between 2001 and 2006, in a clear and accessible PDF format.
Introduction
A diagrammatical and analytical summary of the deals and dealmakers in the therapy area over a five-year period.
Chapter 1: Deals by company
A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.
Chapter 2: Deals by development stage
A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.
Chapter 3: Deal type
Access deal information by type of transaction – see who is licensing or partnering and using what type of deal.
Chapter 4: Industry sector
Deal announcements sorted by industry sector. Choose from nine sectors.
Chapter 5: Top 25 company profiles
Summary profiles for the most active companies in the therapy area over the past five years, including contact details, business strategy, partnering strategy, R&D and history.
Chapter 6: Detailed listing of deals and alliances
A full index of all the deals announced between Jan 2001 and Mar 2006.
Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments.Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments, and links to the full deal in the deal listing at the rear of each report.
|
|
Introduction
About Partneringdesk deals and alliances
Chapter 1: Deals in infectious diseases by company
Chapter 2: Deals in infectious diseases by development stage
Chapter 3: Deals in infectious diseases by type
Chapter 4: Deals in infectious diseases by industry sector
Chapter 5: Summary profiles for the most active companies in infectious diseases
Chapter 6: List of deals
Glossary
Fig. 1 Deal activity 2001-2005
Fig. 2 Deal activity 2005
Fig. 3 Deal activity in infectious diseases by year
Fig. 4 Deal activity in infectious diseases by development stage (early stage)
Fig. 5 Deal activity in infectious diseases by development stage (mid stage)
Fig. 6 Deal activity in infectious diseases by development stage (late stage)
Fig. 7 Deal activity in infectious diseases by type
Fig. 8 Deal activity in infectious diseases by industry sector
|
|
|
PPLSEN
|
|
|
|
|
